光大证券股份有限公司 关于诚达药业股份有限公司 保荐人名称：光大证券股份有限公司 被保荐公司简称：诚达药业 保荐代表人姓名：杨科 联系电话：021-22169999 保荐代表人姓名：范国祖 联系电话：021-22169999 一、保荐工作概述 项目 工作内容 （1）是否及时审阅公司信息披露文件 是 （2）未及时审阅公司信息披露文件的次数 0次 的情况 （1）是否督导公司建立健全规章制度（包 括但不限于防止关联方占用公司资源的制 是 度、募集资金管理制度、内控制度、内部 审计制度、关联交易制度） （2）公司是否有效执行相关规章制度 是 （1）查询公司募集资金专户次数 12 次 （2）公司募集资金项目进展是否与信息披 是 露文件一致 （1）列席公司股东会次数 0次 （2）列席公司董事会次数 0次 （1）现场检查次数 1次 （2）现场检查报告是否按照本所规定报送 是 （3）现场检查发现的主要问题及整改情况 无 （1）发表专项意见次数 6次 （2）发表非同意意见所涉问题及结论意见 无 （1）向本所报告的次数 0次 （2）报告事项的主要内容 不适用 （3）报告事项的进展或者整改情况 不适用 （1）是否存在需要关注的事项 ...

点击注册小程序 查看完整报告 特别申明： 本订阅号中所涉及的证券研究信息由光大证券研究所编写，仅面向光大证券专业投资者客 户，用作新媒体形势下研究信息和研究观点的沟通交流。非光大证券专业投资者客户，请勿 订阅、接收或使用本订阅号中的任何信息。本订阅号难以设置访问权限，若给您造成不便， 敬请谅解。光大证券研究所不会因关注、收到或阅读本订阅号推送内容而视相关人员为光大 证券的客户。 报告摘要 1、 二级市场 2025年5月12日-2025年5月16日（以下简称"本周"），我国已上市公募REITs的二级市场价格整体呈现震荡 上行的趋势：加权REITs指数收于137.87，本周回报率为1.7%。与其他主流大类资产相比，回报率由高至 低排序分别为：美股>REITs>可转债>A股>纯债>原油>黄金。 从项目属性来看，本周产权类REITs和特许经营权类REITs均整体呈现震荡上行趋势，产权类REITs的涨幅 更大。 从底层资产类型来看，从底层资产类型来看，本周消费类REITs涨幅最大。本周回报率排名前三的底层资 产类型分别为消费类、园区类和保障房类。 从单只REIT层面来看，本周公募REITs涨跌互现，有52只REITs上 ...

查看完整报告 特别申明： 本订阅号中所涉及的证券研究信息由光大证券研究所编写，仅面向光大证券专业投资者客 户，用作新媒体形势下研究信息和研究观点的沟通交流。非光大证券专业投资者客户，请勿 订阅、接收或使用本订阅号中的任何信息。本订阅号难以设置访问权限，若给您造成不便， 敬请谅解。光大证券研究所不会因关注、收到或阅读本订阅号推送内容而视相关人员为光大 证券的客户。 报告摘要 点击注册小程序 本周，基本面因子在多数行业表现较差，其中净利润增长率因子在煤炭行业正收益显著。估值类因子中， BP因子在综合行业正收益显著。流动性因子在交通运输、美容护理、化工、商业贸易和轻工制造行业正收 益显著。市值风格上，本周多数行业表现为小市值风格。 PB-ROE-50组合跟踪： 本周PB-ROE-50组合在中证500、中证800股票池中获取正超额收益。中证500股票池中获得超额收益 0.88%，中证800股票池中获得超额收益0.43%，全市场股票池中获得超额收益-0.02%。 量化市场跟踪 大类因子表现： 本周全市场股票池中，残差波动率因子和盈利因子分别获取正收益0.55%、0.26%；市值因子和非线性市值 因子分别获取负收益-0. ...

Core Viewpoint - Jiangxi Yuenan New Materials Co., Ltd. has initiated a stock incentive plan for 2025, which includes the first grant of restricted stocks to selected employees and management, aimed at enhancing motivation and aligning interests with shareholders [1][6][15]. Summary by Sections Independent Financial Advisor Report - The independent financial advisor, Everbright Securities Co., Ltd., has confirmed that the stock incentive plan has undergone necessary approval procedures and complies with relevant regulations [6][15]. - The plan involves granting restricted stocks to 257 individuals, with a total of 1.8753 million shares allocated, adjusted from an initial 1.9173 million shares due to changes in eligible participants [8][15]. Approval Process - The approval process included discussions and resolutions at the board and supervisory committee meetings, ensuring that all necessary checks and balances were in place [6][7]. - The plan was publicly disclosed on the Shanghai Stock Exchange, ensuring transparency and compliance with regulatory requirements [8][15]. Grant Conditions - The grant of restricted stocks is contingent upon the fulfillment of specific conditions, including the absence of negative audit opinions and compliance with legal regulations [9][15]. - The vesting schedule for the restricted stocks is structured over a maximum of 60 months, with specific percentages vesting at designated intervals [11][12]. Impact on Financials - The implementation of the stock incentive plan is expected to have implications for the company's financial status and operational results, which will be assessed in accordance with accounting standards [16][17].

Core Viewpoint - The report summarizes the issuance of convertible bonds by Shandong Zhangqiu Blower Co., Ltd., detailing the amount raised, the use of funds, and the compliance with regulatory requirements [3][9][12]. Group 1: Issuer Basic Information - Shandong Zhangqiu Blower Co., Ltd. has registered capital as of the end of Q1 2025 [3]. - The company issued 2.43 million convertible bonds with a face value of RMB 100 each, raising a total of RMB 24.3 million [3]. Group 2: Fundraising Overview - The net amount raised after deducting issuance costs was RMB 238,629,781.92, with all funds received by October 23, 2023 [3]. - The issuance was approved by the China Securities Regulatory Commission (CSRC) [3]. Group 3: Due Diligence and Continuous Supervision - The sponsor conducted due diligence and complied with regulations during the issuance process, including responding to inquiries from the Shenzhen Stock Exchange [4]. - Continuous supervision included monitoring the company's governance structure and ensuring compliance with commitments and information disclosure [5][6]. Group 4: Fund Usage and Compliance - The company established a special account for the raised funds and has been managing them according to regulations, although there were instances of non-compliance in fund usage that were rectified [9][10]. - The company has been using idle funds for cash management, which is within the regulatory framework and does not affect the normal operation of fundraising projects [10][11]. Group 5: Conclusion on Fund Management - The sponsor concluded that the company's management of raised funds is compliant with relevant regulations, and there are no violations regarding the use of funds [12]. - As of December 31, 2024, some raised funds remain unutilized, and the sponsor will continue to oversee their usage [12].

Investment Rating - The report maintains an "Overweight" rating for the securities industry [1] Core Insights - The report emphasizes the importance of a "sustained, stable, and active capital market" as a key driver for market sentiment and growth [6][7] - It highlights the significant growth in the securities industry, particularly in brokerage and proprietary trading, with a notable increase in revenue and net profit for listed brokers in Q1 2025 [36][37] Summary by Sections 1. Policy Interpretation on "Sustained, Stable, and Active Capital Market" - The report discusses recent policy measures aimed at stabilizing and invigorating the capital market, including support for long-term capital inflows and the promotion of new regulatory frameworks [8][7] - It outlines specific actions from the China Securities Regulatory Commission (CSRC) to enhance market liquidity and investor confidence [8] 2. Securities Industry Q1 2025 Performance Overview and Outlook - In Q1 2025, 42 listed brokers achieved revenues of CNY 125.93 billion, a year-on-year increase of 19%, and a net profit of CNY 52.18 billion, up 77.8% [37][38] - The fastest-growing segments were proprietary trading (up 45.5%) and brokerage services (up 43.2%), while investment banking and asset management saw slight declines [36][37] - The report notes that the average return on equity (ROE) for listed brokers improved to 8.05%, reflecting enhanced profitability across the sector [47][46] 3. Investment Recommendations - The report suggests that the ongoing reforms and market conditions present favorable investment opportunities within the securities sector, particularly in brokerage and proprietary trading [36][37] - It identifies potential benefits for underweighted sectors, indicating a shift in investment strategies towards areas with lower current allocations [15]

务执行能力，完善投行三道防线内控体系建 设。 监会和深交所采取监管措施；翔腾新材不存 在被中国证监会和深交所采取监管措施的情 形。 | 光大证券股份有限公司关于江苏翔腾新材料股份有限公司2024年度 | | | --- | --- | | 保荐工作报告 | | | 保荐机构名称：光大证券股份有限公司 | 被保荐公司简称：翔腾新材 | | 保荐代表人姓名：黄腾飞 | 联系电话：021-22169999 | | 保荐代表人姓名：陈姝婷 | 联系电话：021-22169999 | | 一、保荐工作概述 | | | 项目 | 工作内容 | | （1）是否及时审阅公司信息披露文件 | 是 | | （2）未及时审阅公司信息披露文件的次数 | 0次 | | 情况 | | | （1）是否督导公司建立健全规章制度（包括 | | | 但不限于防止关联方占用公司资源的制度、 | | | 是 | | | 募集资金管理制度、内控制度、内部审计制 | | | 度、关联交易制度） | | | （2）公司是否有效执行相关规章制度 | 是 | | （1）查询公司募集资金专户次数 | 12 次 | | （2）公司募集资金项目进展是否与信息披露 ...

Summary of Key Points Core Viewpoint - The report outlines the continuous supervision and compliance measures taken by Everbright Securities for Anhui Hongyu Wuzhou Medical Devices Co., Ltd, highlighting the challenges faced by the company in terms of declining revenue and profit due to global trade policies and market competition [1][4]. Group 1: Company Performance - The company's net profit attributable to shareholders decreased by 33.68%, amounting to 39.97 million yuan, compared to 60.27 million yuan in the same period of 2023 [1]. - Revenue also saw a decline of 10.54%, with a reduction of 5.63 million yuan, totaling 533.68 million yuan [1]. - The company is urged to adopt proactive measures to address international market changes, enhance customer acquisition, control costs, and improve product competitiveness [1]. Group 2: Regulatory Compliance - Everbright Securities has conducted timely reviews of the company's information disclosure documents, with no instances of late reviews [1]. - The company has established and effectively executed regulations to prevent related party transactions and manage fundraising [1]. - A training session was held on December 27, 2024, focusing on compliance with regulations regarding information disclosure and fundraising management [2]. Group 3: Supervision and Governance - The report indicates that there were no significant issues found during the supervision process, and all commitments made by the company and its shareholders were fulfilled [2]. - Everbright Securities has faced regulatory scrutiny, receiving warnings from the China Securities Regulatory Commission and Shenzhen Stock Exchange, prompting a commitment to enhance compliance and internal controls [3][4]. - The company has actively rectified issues raised in regulatory communications and is committed to ensuring accurate and complete information disclosure [4].

Core Insights - The leading Chinese securities firms are accelerating their strategic layout for Hong Kong IPOs, supported by coordinated domestic and foreign policies [1] - The performance of the brokerage industry is expected to significantly recover in 2024, driven by favorable policies, increasing proprietary income, and a low base effect from 2023 [1] - In 2025, continued market recovery is anticipated, with increases in stock trading volume, financing balance, and equity fund issuance, which will further boost wealth management income for brokerages [1] Industry Summary - Major brokerages are expected to see a substantial year-on-year increase in net profit in Q1 2025, with a 92% rise in net profit attributable to shareholders and a 51% increase in net profit excluding non-recurring items [1] - Three main trends are highlighted: 1. Continued expansion of total assets driven by financial investment scale, though there is a divergence in leverage ratios [1] 2. Growth in investment contributions, with major brokerages experiencing a general increase in investment-related income, indicating strong elasticity [1] 3. Recovery of light capital businesses, with a 71% year-on-year increase in average daily stock fund transaction volume and improvements in brokerage net income and investment banking net income [1] Future Outlook - The political bureau's meeting has set the tone for a stable and active capital market, with expectations for continued supportive policies for the capital market [1] - Attention is drawn to leading brokerages with strong balance sheet management and stable performance growth, as well as structural opportunities related to mergers and acquisitions [1] Related Companies - Companies with significant AH price differences include China International Capital Corporation (03908), CITIC Securities (06030), Everbright Securities (06178), CITIC Jiantou Securities (06066), Hongye Futures (03678), and GF Securities (01776) [2]

中国经济网北京5月13日讯奥雅股份（300949）(300949.SZ)近日披露的2025年一季度报告显示，报告期 内，该公司实现营业收入8892.08万元，同比下降44.04%；实现归属于上市公司股东的净利润-932.57万 元，上年同期为-3859.06万元；实现归属于上市公司股东的扣除非经常性损益的净利润-1089.20万元， 较上年同期1160.96万元下降193.82%；经营活动产生的现金流量净额为3376.83万元，上年同期 为-2773.78万元。 2022年至2024年，奥雅股份实现营业收入分别为4.80亿元、4.79亿元和4.13亿元，实现归属于上市公司 股东的净利润分别为-5168.25万元、-1.77亿元和-2.82亿元，实现归属于上市公司股东的扣除非经常性损 益的净利润分别为-7626.32万元、-2.04亿元和-1.95亿元，经营活动产生的现金流量净额分别为-9080.02 万元、-1.17亿元和-2163.79万元。 上市首日，奥雅股份盘中最高价报143.00元，为该股上市以来最高价。该股目前处于破发状态。 奥雅股份首次公开发行股票募集资金总额为81,345.00万元，募集资金净额 ...